Related references
Note: Only part of the references are listed.Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysis
Jiaye Liu et al.
HEPATOLOGY RESEARCH (2018)
Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals
Pamela S. Belperio et al.
HEPATOLOGY (2017)
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
Akira Doi et al.
HEPATOLOGY RESEARCH (2017)
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
Xavier Forns et al.
LANCET INFECTIOUS DISEASES (2017)
Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients
Astrid Marot et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Factors influencing immunologic response to hepatitis B vaccine in adults
Shigui Yang et al.
SCIENTIFIC REPORTS (2016)
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients
Gia L. Tyson et al.
HEPATOLOGY (2013)
Immune Response of Hepatitis B Vaccine Among Persons With Diabetes A systematic review of the literature
Sarah F. Schillie et al.
DIABETES CARE (2012)
Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population
Hiroyoshi Doi et al.
HEPATOLOGY (2012)
Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4+ T cell responses
Jonathan P. Moorman et al.
VACCINE (2011)
Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: The effect of pegylated interferon plus ribavirin treatment
Ioannis S. Elefsiniotis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
T Bauer et al.
VACCINE (2006)
Antibody response to hepatitis B vaccine in end-stage renal disease patients
Kai Ming Chow et al.
NEPHRON CLINICAL PRACTICE (2006)
Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination
EB Keeffe
AMERICAN JOURNAL OF MEDICINE (2005)
Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension
R de Franchis
JOURNAL OF HEPATOLOGY (2005)
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better
G DaRoza et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study
V Leroy et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults
IJ Tsai et al.
VACCINE (2000)
Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen
F Rahman et al.
HEPATOLOGY (2000)
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
M Wiedmann et al.
HEPATOLOGY (2000)
Share Paper
